MARY MEACHAM: Open Payments
NPI 1265207534 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$110 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $128 · 2025 $110
Food & beverage: $110
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Viatris Specialty LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| PFIZER INC. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: FARXIGA, YUPELRI, CAPLYTA, PAXLOVID, VRAYLAR.
Industry payments across ID — which companies pay providers there.
